AU2002367943A8 - Improved reagents and methods for producing parvoviruses - Google Patents

Improved reagents and methods for producing parvoviruses

Info

Publication number
AU2002367943A8
AU2002367943A8 AU2002367943A AU2002367943A AU2002367943A8 AU 2002367943 A8 AU2002367943 A8 AU 2002367943A8 AU 2002367943 A AU2002367943 A AU 2002367943A AU 2002367943 A AU2002367943 A AU 2002367943A AU 2002367943 A8 AU2002367943 A8 AU 2002367943A8
Authority
AU
Australia
Prior art keywords
parvoviruses
producing
methods
improved reagents
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002367943A
Other versions
AU2002367943A1 (en
Inventor
Joseph E Rabinowitz
Richard Jude Samulski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
University of North Carolina System
Original Assignee
University of North Carolina at Chapel Hill
University of North Carolina System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill, University of North Carolina System filed Critical University of North Carolina at Chapel Hill
Publication of AU2002367943A1 publication Critical patent/AU2002367943A1/en
Publication of AU2002367943A8 publication Critical patent/AU2002367943A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002367943A 2001-12-18 2002-12-02 Improved reagents and methods for producing parvoviruses Abandoned AU2002367943A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34191901P 2001-12-18 2001-12-18
US60/341,919 2001-12-18
PCT/US2002/038423 WO2003104392A2 (en) 2001-12-18 2002-12-02 Improved reagents and methods for producing parvoviruses

Publications (2)

Publication Number Publication Date
AU2002367943A1 AU2002367943A1 (en) 2003-12-22
AU2002367943A8 true AU2002367943A8 (en) 2003-12-22

Family

ID=29735975

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002367943A Abandoned AU2002367943A1 (en) 2001-12-18 2002-12-02 Improved reagents and methods for producing parvoviruses

Country Status (2)

Country Link
AU (1) AU2002367943A1 (en)
WO (1) WO2003104392A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8241622B2 (en) 2001-07-13 2012-08-14 University Of Iowa Research Foundation Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
BRPI0214119B8 (en) 2001-11-13 2021-05-25 Univ Pennsylvania recombinant adeno-associated virus, method of generating said virus and composition comprising said virus
PT1453547T (en) 2001-12-17 2016-12-28 Univ Pennsylvania Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
SI3116900T1 (en) 2014-03-09 2021-02-26 The Trustees Of The University Of Pennsylvania Compositions useful in treatment of ornithine transcarbamylase (otc) deficiency
WO2017139381A1 (en) 2016-02-08 2017-08-17 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
CA3198936A1 (en) 2016-03-07 2017-09-14 University Of Iowa Research Foundation Aav-mediated expression using a synthetic promoter and enhancer
EP3456822A1 (en) * 2017-09-19 2019-03-20 CEVEC Pharmaceuticals GmbH Inducible aav rep genes
WO2019173538A1 (en) * 2018-03-06 2019-09-12 University Of Florida Research Foundation, Incorporated Aav chimeras
CN108465107B (en) * 2018-06-05 2020-02-21 山东信得科技股份有限公司 Duck type 2 adenovirus and Muscovy duck parvovirus disease combined inactivated vaccine
US10557149B1 (en) * 2019-07-15 2020-02-11 Vigene Biosciences, Inc. Recombinantly-modified adeno-associated virus helper vectors and their use to improve the packaging efficiency of recombinantly-modified adeno-associated virus
WO2023220043A1 (en) * 2022-05-09 2023-11-16 Synteny Therapeutics, Inc. Erythroparvovirus with a modified genome for gene therapy
WO2023220035A1 (en) * 2022-05-09 2023-11-16 Synteny Therapeutics, Inc. Erythroparvovirus compositions and methods for gene therapy

Also Published As

Publication number Publication date
WO2003104392A9 (en) 2004-04-29
WO2003104392A2 (en) 2003-12-18
AU2002367943A1 (en) 2003-12-22
WO2003104392A3 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
GB0111020D0 (en) Process
EP1378749A4 (en) Screening method
GB0109555D0 (en) Process
GB0108968D0 (en) Methods
GB0104948D0 (en) Novel methods
AU2002367943A8 (en) Improved reagents and methods for producing parvoviruses
GB2380993B (en) Nickel refining method
GB0126251D0 (en) Methods
GB0111004D0 (en) Screening method
GB0111146D0 (en) Methods
GB0112331D0 (en) Process
GB0116249D0 (en) Methods
EP1361283A4 (en) Novel assay method
GB0124577D0 (en) Novel methods
GB2379444B (en) Assay Method
GB0118549D0 (en) Methods
GB0112327D0 (en) Process
GB0127344D0 (en) Assay method
GB0128964D0 (en) Assays, methods and means
GB0118611D0 (en) Methods
GB0117193D0 (en) Protein modification reagents
GB0125666D0 (en) Analysis method
GB0103156D0 (en) Analysis method
GB0114309D0 (en) Assay method
GB0123388D0 (en) Assays,methods and means

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase